This study provides a novel basis for screening potential biomarkers in the macrophage mTOR–cholesterol homeostasis–polarization regulatory signaling pathway and evaluating targeted interventions for HBx-associated NASH. Here, MTOR is linked to metabolic dysfunction-associated steatohepatitis.